What is the latest published AMGN stock rating?

Amgen Inc. is shown with Buy in the latest published report, analyzed 2026-09-08. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AMGN analysis?

The full latest published report, analyzed 2026-09-08, lives at /stocks/AMGN/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for AMGN?

The latest published report analyzed 2026-09-08 gives AMGN a fair value of USD 492 and a potential value of USD 641. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the AMGN page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-09-08). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

AMGN Stock: Fundamentals & Analysis | StockMarketAgent.AI

Amgen Inc. (AMGN)

NASDAQ: AMGN · USD

—

StockMarketAgent Research · Analyzed 2026-09-08

Our latest published analysis: AMGN rated Buy

Amgen Inc.'s published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$492 / share

Potential value

$641 / share

Upside to FV

+12.5%

Moat

1/10

None

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$236.4B
P/E (forward)	18.2x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

P/E (forward): 18.2x
Market cap: $236.4B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$25.98B	$26.32B	$28.19B	$33.42B	$36.75B	+9.1%
Gross profit	$19.53B	$19.92B	$19.74B	$20.57B	$26.01B	+7.4%
Operating income	$7.64B	$9.57B	$7.90B	$7.26B	$9.08B	+4.4%
Net income	$5.89B	$6.55B	$6.72B	$4.09B	$7.71B	+7.0%
EPS (diluted)	$10.28	$12.11	$12.49	$7.56	$14.23	+8.5%
EBITDA	$11.30B	$12.17B	$7.90B	$13.36B	$16.90B	+10.6%
R&D	$6.32B	$4.43B	$4.78B	$5.96B	$6.97B	+2.5%
SG&A	$5.37B	$5.41B	$6.18B	$7.10B	$7.05B	+7.1%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	—	—	—	—	—	—	卖出
ABNB	Airbnb, Inc.	—	—	—	—	—	—	卖出
ADBE	Adobe Inc.	—	—	—	—	—	—	强力买入
ABBV	AbbVie Inc.	—	—	—	—	—	—	卖出
ABT	Abbott Laboratories	—	—	—	—	—	—	减持
ALGN	Align Technology Inc.	—	—	—	—	—	—	减持

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($492.07). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	1.5%	2.0%	2.5%	3.0%	3.5%
5.6%	$582	$623	$679	$763	$906
6.6%	$509	$532	$561	$599	$651
7.6%	$461	$475	$492	$513	$540
8.6%	$426	$435	$447	$460	$476
9.6%	$399	$406	$414	$423	$433

Scorecard

Published factor rows and weighted composite

Valuation7.5

Management6.5

Balance Sheet3.5

Profitability7.5

Revenue Growth6.0

Risk Assessment5.0

Competitive Moat1.0

Earnings Quality9.0

Capital Efficiency7.5

Weighted composite

5.9/10

Mixed

Category	Score	Reading
Valuation	7.5
Management	6.5
Balance Sheet	3.5
Profitability	7.5
Revenue Growth	6.0
Risk Assessment	5.0
Competitive Moat	1.0
Earnings Quality	9.0
Capital Efficiency	7.5

评级历史

每月发布的研究版本所给出的评级。评级比较分析日的价格与公允价值，并不记录判断是否正确。

年份	1月	2月	3月	4月	5月	6月	7月	8月	9月	10月	11月	12月
2026

强力买入
持有

Amgen Inc. (AMGN)

Our latest published analysis: AMGN rated Buy

Price

Financial snapshot

Fair-value bridge

Latest news · AMGN

Valuation

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

Deeper analysis on AMGN

Frequently asked questions

评级历史